iShares Genomics Immunology and Healthcare ETF (IDNA) Short Interest Ratio & Short Volume

Short interest is the volume of iShares Genomics Immunology and Healthcare ETF shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 28,000 shares of IDNA short. Learn More on iShares Genomics Immunology and Healthcare ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDNA shares currently have a short interest ratio of 1.0. Learn More on iShares Genomics Immunology and Healthcare ETF's short interest ratio.

iShares Genomics Immunology and Healthcare ETF saw a drop in short interest during the month of September. As of September 15th, there was short interest totaling 28,000 shares, a drop of 26.5% from the previous total of 38,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to iShares Genomics Immunology and Healthcare ETF: Global X Millennial Consumer ETF (0.30%), VanEck Social Sentiment ETF (11.87%), Amplify Seymour Cannabis ETF (0.30%), Xtrackers US National Critical Technologies ETF (0.08%), KraneShares China Internet and Covered Call Strategy ETF (2.71%), Spear Alpha ETF (5.75%), Procure Space ETF (4.78%), iShares ESG Advanced MSCI EM ETF (1.48%), Sovereigns Capital Flourish Fund (0.14%), AXS Change Finance ESG ETF (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling IDNA is an investing strategy that aims to generate trading profit from iShares Genomics Immunology and Healthcare ETF as its price is falling. IDNA shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Genomics Immunology and Healthcare ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDNA, twice per month. The most recent reporting period available is September, 15 2025.